JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
VRDN Financials - Viridian Therapeutics, Inc.de Income & Cash Flow | Ledgeburg
VRDN - Viridian Therapeutics, Inc.de
USD | NASDAQ | Healthcare
Summary
Summary VRDN Stock
Financials
Financials VRDN Stock
Loading...
Loading...
Income Statement
Income Statement VRDN Stock
Balance Sheet
Balance Sheet VRDN Stock
Cash Flow Statement
Cash Flow Statement VRDN Stock
Loading...
Loading...
Home
Stocks
Viridian Therapeutics, Inc.de (VRDN)
Financials
Financials of VRDN
Loading...
Loading...
Loading...
Loading...
Revenue
$70.849M
Operating Income
$-363.395M
Net Income
$-342.601M
Share Count (Basic)
N/A
Operating Cash Flow
$-276.391M
Free Cash Flow
$-276.886M
Cash And Short-Term Equivalents
N/A
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
20M
40M
60M
80M
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue $USD
0
20M
40M
60M
80M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
-300M
-200M
-100M
FY2021
Annual
Quarterly
Margins
Gross
Operating
Net
-100000%
-80000%
-60000%
-40000%
-20000%
0%
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-120M
-100M
-80M
-60M
-40M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-150000%
-100000%
-50000%
0%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26